Anthrax (Malignant Pustule) | Figure 4.12 A: Cutaneous diphtheria (Courtesy of Public Health Image Library: CDC) B: Cutaneous anthrax (Courtesy of James Steele, CDC) C: Erysipeloid (Reprint from Mandell G, ed. Atlas of Infectious Diseases. Philadelphia PA: Current Medicine LLC; 2002) |
(Figure 4.12B) - Acute disease in humans and animals caused by Bacillus anthracis, a Gram-positive spore-forming rod
- Clinical forms: cutaneous, pulmonary, and GI
- Cutaneous form : “malignant pustule” at inoculation site which spreads and becomes hemorrhagic → central eschar with surrounding nonpitting edema → eschar sloughs leaving shallow ulceration
- Virulence factors: capsule and two exotoxins: e dema toxin (increases cAMP levels) and lethal toxin (increases TNFα and IL1 β promoting shock/death)
- Bioterorism-associated treatment: ciprofloxacin or doxycycline (conventional treatment: PCN)
|